Regulatory Professionals

Regulatory Affairs Recruitment

Close
  • Job Search
    • Vacancies
    • Our Services
      • Lifecycle Management
      • Regulatory Writing
      • Regulatory Submissions and Publishing
      • Regulatory CMC
      • Regulatory Clinical
      • Medical Devices
  • Candidates
    • Send Us Your CV
    • Downloads
    • Regulatory Glossary
    • Regulatory Professionals’ Pipeline Watch
    • Referral Scheme
    • Contracting
    • Permanent
    • EAA Regulations
  • Employers
    • Integrated Regulatory Outsourcing
    • Contract Staffing Solution
    • Permanent Staffing Solutions
    • Client Testimonials
  • About Us
    • News
    • CP Group
    • Work For Us
    • Privacy Policy
  • Contact Us
  • Account
Menu

Bristol-Myers Squibb

Written by Kathleen McCarthy
October 14, 2015

Bristol-Myers Squibb’s Opdivo Gains Expanded FDA Approval in Previously-Treated Metastatic Non-Small Cell Lung Cancer

The US drugs safety regulator has fast-tracked the approval of Opdivo (nivolumab) to extend its current use to a new group of patients with advanced lung cancer.

Continue Reading

Written by Kathleen McCarthy
September 18, 2015

FDA say Opdivo is a Breakthrough in Kidney Cancer

Bristol-Myers Squibb (BMS) moves closer to approval of its checkpoint inhibitor Opdivo in kidney cancer after obtaining FDA ‘breakthrough’ status for the cancer immunotherapy in that indication. The designation comes after Opdivo (nivolumab) was shown to be effective as a treatment for renal cell carcinoma in a phase III trial reported in July.

Continue Reading

Written by Kathleen McCarthy
June 23, 2015

BMS’ Opdivo First EU Approved PD-1 Inhibitor

Bristol-Myers Squibb’s (BMS’) Opdivo for the use in treatment for advanced skin cancer (unresectable or metastatic melanoma in adults) has been the first PD-1 inhibitor to gain approval by the European regulators. Last summer, the inhibitor became the first PD-1 inhibitor to be approved in the world when Japanese regulators approved it. In the US,

Continue Reading

Categories

  • News
  • Awards
  • Company Info
  • Exhibition/Conference
  • Industry News
  • Job Boards
  • Only Medics
  • Social Media

Tags

ADHD Aenova Alexion Amylin Anadys Pharmaceuticals Antibiotics AstraZeneca Atrium Medical Corporation BMS Boehringer Cell Carcinoma Cell Therapeutics Conference/Exhibition Cortex DIPEx Dompe EU EU Approval Forest Galapagos Horizon Pharma Horizon Therapeutics Industry news Institute of Cancer Research KOL Leif Johansson Mayo Clinic McLaren MolMed MSD NIHR non-Hodgkin lymphoma Opening Times Optimer Pharmaceuticals Pharmaceutical and Biotechnology Pharmaceutical Jobs Pulmonary Embolism Puma Biotechnology research2guidance Research and Development Shire Skin Cancer Teva Theravance Vertex

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
apply@regulatoryprofessionals.com or 0118 9522 797

The Clinical Professionals group of Companies.

CP Group

Job Alerts

Want personalised Job alerts delivered to you periodically?
Click the link below to register your details:



Job Alerts

Your Dashboard

Your account allows you to easily apply for roles, setup job alerts and bookmark positions to view later.

Click below to view your dashboard:

Dashboard

Our Offices

C/O Clinical Professionals,
33 Blagrave Street,
Reading, RG1 1PW, UK
0118 9522 797

C/O Clinical Professionals EU,
5 Old Bailey
London, EC4M 7BA, UK
+ 44 (0)207 822 1710

© 2022 Regulatory Professionals — All Rights Reserved
Facebook Twitter Google Linked In
Back to Top